Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Parkinsonian Disorders (chemically induced) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Parkinsonian Disorders (cerebrospinal fluid) < Parkinsonian Disorders (chemically induced) < Parkinsonian Disorders (classification)  Facettes :

List of bibliographic references indexed by Parkinsonian Disorders (chemically induced)

Number of relevant bibliographic references: 35.
[0-20] [0 - 20][0 - 35][20-34][20-40]
Ident.Authors (with country if any)Title
000C90 (2012) Elisa Franquet [Espagne] ; Maria Salvad Figueres ; Carlos Lorenzo-Bosquet ; Gemma Cuberas-Borr S ; Alex Rovira ; Joan Castell-Conesa ; Jorge Hernandez-VaraNigrostriatal pathway dysfunction in a methanol-induced delayed dystonia-parkinsonism.
001404 (2011) María Elena Erro [Espagne] ; Roberto Mu Oz [Espagne] ; Beatriz Zandio [Espagne] ; Sergio Mayor [Espagne]Reversible Parkinsonism after accidental oral intake of mancozeb
001579 (2011) Elisa Garbayo [Espagne] ; Eduardo Ansorena [Espagne] ; Jose Luis Lanciego [Espagne] ; María Jose Blanco-Prieto [Espagne] ; María S. Aymerich [Espagne]Long‐term neuroprotection and neurorestoration by glial cell‐derived neurotrophic factor microspheres for the treatment of Parkinson's disease
001A87 (2010) Myung Sik Lee [Corée du Sud] ; Chul Hyoung Lyoo [Corée du Sud] ; Yoon Ho Choi [Corée du Sud]Primary progressive freezing gait in a patient with CO‐induced parkinsonism
001B13 (2010) Chadwick W. Christine [États-Unis] ; Elisabeth R. Garwood [États-Unis] ; Lauren E. Schrock [États-Unis] ; Daniel E. Austin [États-Unis] ; Charles E. Mcculloch [États-Unis]Parkinsonism in patients with a history of amphetamine exposure
002066 (2009) Helen Ling [Thaïlande] ; Roongroj Bhidayasiri [Thaïlande]Reversible Parkinsonism after chronic cyclosporin treatment in renal transplantation
002536 (2008) Michele Tinazzi [Italie] ; Sarah Ottaviani [Italie] ; Ioannis U. Isaias [Italie] ; Isabella Pasquin [Italie] ; Maria Steinmayr [Italie] ; Claudio Vampini [Italie] ; Manuela Pilleri [Italie] ; Giuseppe Moretto [Italie] ; Antonio Fiaschi [Italie] ; Nicola Smania [Italie] ; Piergiorgio Giorgetti [Italie] ; Angelo Antonini [Italie][123I]FP‐CIT SPET imaging in drug‐induced Parkinsonism
002705 (2008) Marianna Selikhova [Royaume-Uni, Russie] ; Ljuda Fedoryshyn [Ukraine] ; Yuri Matviyenko [Ukraine] ; Irena Komnatska [Ukraine] ; Marianna Kyrylchuk [Ukraine] ; Lesrek Krolicki [Pologne] ; Andrzej Friedman [Pologne] ; Andrew Taylor [Royaume-Uni] ; H. Rolf J Ger [Royaume-Uni] ; Andrew Lees (neurologue) [Royaume-Uni] ; Yanush Sanotsky [Ukraine]Parkinsonism and dystonia caused by the illicit use of ephedrone—A longitudinal study
002789 (2008) Jose L. Lanciego [Espagne] ; Maria C. Rodríguez-Oroz [Espagne] ; Francisco J. Blesa [Espagne] ; Lydia Alvarez-Erviti [Espagne] ; Jorge Guridi [Espagne] ; Pedro Barroso-Chinea [Espagne] ; Yoland Smith [États-Unis] ; Jose A. Obeso [Espagne]Lesion of the centromedian thalamic nucleus in MPTP‐treated monkeys
002B04 (2007) Dominic Jamora [Singapour, Philippines] ; Shih-Hui Lim [Singapour] ; Andrew Pan [Singapour] ; Louis Tan [Singapour] ; Eng-King Tan [Singapour]Valproate‐induced Parkinsonism in epilepsy patients
002C47 (2007) Kazumasa Suzuki [Japon] ; Takehisa Takano [Japon] ; Kae Ito [Japon] ; Yukio Ebina [Japon] ; Hiroo Matsuoka [Japon] ; Shuichi Awata [Japon]Prolonged residual catatonia or prolonged neuroleptic‐induced Parkinsonism following catatonic stupor in a patient with manic–depressive illness
002D65 (2007) Martin Köllensperger [Autriche] ; Nadia Stefanova [Autriche] ; Markus Reindl [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Loss of dopaminergic responsiveness in a double lesion rat model of the Parkinson variant of multiple system atrophy
002F00 (2007) Graeme J. A. Macphee [Royaume-Uni] ; David A. Stewart [Royaume-Uni]Diagnosis of Parkinsonism in older patients receiving sodium valproate
003116 (2006) Mordechai Lorberboym [Israël] ; Therese A. Treves [Israël] ; Eldad Melamed [Israël] ; Yair Lampl [Israël] ; Mark Hellmann [Israël] ; Ruth Djaldetti [Israël][123I]‐FP/CIT SPECT imaging for distinguishing drug‐induced parkinsonism from Parkinson's disease
003277 (2006) Naomi P. Visanji [Canada] ; Jordi Gomez-Ramirez [Canada] ; Tom H. Johnston [Canada] ; Donna Pires [Canada] ; Valerie Voon [Canada, États-Unis] ; Jonathan M. Brotchie [Canada] ; Susan H. Fox [Canada]Pharmacological characterization of psychosis‐like behavior in the MPTP‐lesioned nonhuman primate model of Parkinson's disease
003286 (2006) Patrick Santens [Belgique] ; Isabel Claeys [Belgique] ; Kristl Vonck [Belgique] ; Paul Boon [Belgique]Parkinsonism due to lamotrigine
003526 (2006) Concepci Marin [Espagne] ; Esther Aguilar [Espagne] ; José A. Obeso [Espagne]Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats
003534 (2006) Roberta Frigerio [États-Unis] ; Kevin R. Sanft [États-Unis] ; Brandon R. Grossardt [États-Unis] ; Brett J. Peterson [États-Unis] ; Alexis Elbaz [France] ; James H. Bower [États-Unis] ; J. Eric Ahlskog [États-Unis] ; Mariza De Andrade [États-Unis] ; Demetrius M. Maraganore [États-Unis] ; Walter A. Rocca [États-Unis]Chemical exposures and Parkinson's disease: A population‐based case–control study
003569 (2006) Gloria E. Meredith [États-Unis] ; Un Jung Kang [États-Unis]Behavioral models of Parkinson's disease in rodents: A new look at an old problem
003587 (2006) Mirdhu Wickremaratchi [Royaume-Uni] ; Huw R. Morris [Royaume-Uni] ; Imad M. Ali [Royaume-Uni]Aripiprazole associated with severe exacerbation of Parkinson's disease
003680 (2005) Manfred Hauben [États-Unis] ; Lester Reich [États-Unis]Valproate‐induced parkinsonism: Use of a newer pharmacovigilance tool to investigate the reporting of an unanticipated adverse event with an “old” drug

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinsonian Disorders (chemically induced)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinsonian Disorders (chemically induced)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinsonian Disorders (chemically induced)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024